Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Prev Cardiol ; 27(18): 1996-2003, 2020 12.
Article in English | MEDLINE | ID: mdl-32673508

ABSTRACT

BACKGROUND: A wrong traditional belief persists among people that opium consumption beneficially affects cardiovascular disease and its risk factors. However, no evidence exists regarding the effect of opium consumption or cessation on the long-term risk of major adverse cardio-cerebrovascular events after coronary artery bypass grafting. We therefore aimed to evaluate the effect of persistent opium consumption after surgery on the long-term outcomes of coronary artery bypass grafting. METHODS: The study population consisted of 28,691 patients (20,924 men, mean age 60.9 years), who underwent coronary artery bypass grafting between 2007 and 2016 at our centre. The patients were stratified into three groups according to the status of opium consumption: never opium consumers (n = 23,619), persistent postoperative opium consumers (n = 3636) and enduring postoperative opium withdrawal (n = 1436). Study endpoints were 5-year mortality and 5-year major adverse cardio-cerebrovascular events, comprising all-cause mortality, acute coronary syndrome, cerebrovascular accident and revascularisation. RESULTS: After surgery, 3636 patients continued opium consumption, while 1436 patients persistently avoided opium use. The multivariable survival analysis demonstrated that persistent post-coronary artery bypass grafting opium consumption increased 5-year mortality and 5-year major adverse cardio-cerebrovascular events by 28% (hazard ratio (HR) 1.28, 95% confidence interval (CI) 1.06-1.54; P = 0.009) and 25% (HR 1.25, 95% CI 1.13-1.40; P < 0.0001), respectively. It also increased the 5-year risk of acute coronary syndrome by 34% (sub-distribution HR 1.34, 95% CI 1.16-1.55; P < 0.0001). CONCLUSIONS: The present data suggest that persistent post-coronary artery bypass grafting opium consumption may significantly increase mortality, major adverse cardio-cerebrovascular events and acute coronary syndrome in the long term. Future studies are needed to confirm our findings.


Subject(s)
Coronary Artery Bypass , Coronary Artery Disease/surgery , Opioid-Related Disorders/complications , Opium/adverse effects , Postoperative Complications/etiology , Risk Assessment/methods , Coronary Artery Disease/epidemiology , Female , Follow-Up Studies , Humans , Incidence , Iran/epidemiology , Male , Middle Aged , Narcotics/adverse effects , Postoperative Complications/epidemiology , Retrospective Studies , Time Factors
3.
J Opioid Manag ; 5(6): 365-72, 2009.
Article in English | MEDLINE | ID: mdl-20073410

ABSTRACT

OBJECTIVE: Opium is an overwhelming public health problem in some countries. Different studies have suggested this drug as a risk factor for cardiovascular disease. Although the effect of opium on immune system, lung disease, nephropathy, stroke, and cardiac arrhythmia has been found in different studies, its effect on postoperation complications is not clear yet. The authors conducted this study to assess the effect of opium on post operation in hospital complications among patients who underwent coronary artery bypass graft. DESIGN: The authors retrospectively analyzed the data in this study. SETTING: This study has been done at Tehran Heart Center. PATIENTS: A total of 4,398 patients who had undergone isolated CABG were studied. MAIN OUTCOME MEASURE: Patients who fulfilled the DSM-IV-TR criteria for opium dependence (by smoking) were enrolled as Opium Dependent Patients. Also outcome variables were: Perioperative MI, septicemia, UTI, TIA, continuous coma, prolonged ventilation, pulmonary embolism, renal failure, acute limb ischemia, heart block, AF, mortality. RESULTS: The prevalence of opium dependence was 15.6percent among patients. The authors used a propensity matched model to analyze the relationship between opium and post operation complications. The authors adjusted opium and non-opium dependent patients in all of the baseline preoperative risk factors, so all of the matched patients were same and there was no bias in assessment. CONCLUSION: Opium dependent patients had significantly longer resource utilization. However, no significant relationship was found between opium dependence and other cardiac and non cardiac in hospital complications.


Subject(s)
Analgesics, Opioid , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/surgery , Opioid-Related Disorders/complications , Opium , Postoperative Complications/etiology , Aged , Coronary Artery Bypass/mortality , Coronary Artery Disease/complications , Coronary Artery Disease/mortality , Female , Hospital Mortality , Humans , Iran/epidemiology , Length of Stay , Male , Middle Aged , Opioid-Related Disorders/mortality , Postoperative Complications/mortality , Postoperative Complications/therapy , Prevalence , Propensity Score , Retrospective Studies , Risk Assessment , Risk Factors , Treatment Outcome
4.
J Cardiothorac Anesth ; 2(3): 297-302, 1988 Jun.
Article in English | MEDLINE | ID: mdl-17171863

ABSTRACT

The safety and efficacy of propofol, a new intravenous anesthetic agent, have been demonstrated in healthy patients. Twenty-one patients, ASA III-IV, undergoing elective myocardial revascularization, were randomly chosen to receive either propofol, 2.5 mg/kg, or thiamylal, 4 mg/kg. for the induction of anesthesia. Hemodynamics were recorded at one and three minutes after drug administration during spontaneous respiration. After the addition of halothane and pancuronium with controlled ventilation, measurements were made immediately prior to and one minute after intubation. Five patients were dropped from the study, four due to airway problems and one due to severe hypotension following an induction dose of propofol. Statistics were done using data from the remaining 16 patients, eight in each group. Administration of propofol resulted in significant decreases in mean arterial pressure (MAP), systemic vascular resistance (SVR), and left ventricular stroke work index (LVSWI); as well as an increase in heart rate (HR). These changes were further accentuated by the addition of halothane and pancuronium prior to intubation. Patients in the thiamylal group experienced no significant hemodynamic changes until halothane and pancuronium were added and controlled ventilation was instituted. With these additions, the thiamylal group showed significant decreases in MAP and LVSWI immediately prior to intubation. Both groups experienced significant increases in HR following intubation, but no evidence of myocardial ischemia was seen in either group. All other parameters returned toward control values. Propofol appeared to be safe and effective for the induction of anesthesia in this group of patients, although its hemodynamic effects were greater than those of thiamylal.


Subject(s)
Anesthetics, Intravenous/pharmacology , Blood Pressure/drug effects , Heart Rate/drug effects , Myocardial Revascularization/methods , Propofol/pharmacology , Thiamylal/pharmacology , Adult , Aged , Anesthesia, Intravenous/methods , Anesthetics, Combined/pharmacology , Anesthetics, Inhalation/administration & dosage , Anesthetics, Intravenous/adverse effects , Coronary Artery Disease/surgery , Elective Surgical Procedures , Halothane/administration & dosage , Humans , Intubation, Intratracheal , Middle Aged , Neuromuscular Nondepolarizing Agents/administration & dosage , Pancuronium/administration & dosage , Propofol/adverse effects , Respiration, Artificial , Thiamylal/adverse effects , Time Factors , Vascular Resistance/drug effects
5.
J Cardiothorac Anesth ; 2(2): 177-81, 1988 Apr.
Article in English | MEDLINE | ID: mdl-17171909

ABSTRACT

A method of rapid-sequence induction was studied in 18 patients undergoing coronary artery bypass grafting (CABG) to assess the adequacy of relaxation for endotracheal intubation without resulting in major changes in heart rate (HR). Ten patients received vercuronium, 0.2 mg/kg (V); and eight patients received vecuronium, 0.1 mg/kg, and pancuronium, 0.1 mg/kg (V + P). All patients then received fentanyl, 50 to 70 microg/kg, or sufentanil, 5 to 7 microg/kg, followed 60 seconds later by intubation. Patients were assessed for ulnar and mandibular nerve response to train-of-four (TOF) and tetanic (T) stimulation at 60 seconds; presence or absence of coughing or bucking; degree of vocal cord relaxation (1=none, 2=some, 3=complete relaxation); ability to intubate at 60 seconds; and changes in HR. At the time of intubation, 17 patients had four twitches to TOF and a positive response to T stimulation of the ulnar nerve, while all 18 patients had zero or one twitch to TOF and only four had a positive response to T stimulation of the mandibular nerve (P < .0001 for T and TOF, ulnar v mandibular). Coughing and bucking were not observed in any patient. Vocal cord position was "3" in 14 patients and "2" in four patients. All patients were intubated without difficulty. The mean change in HR was -4.1 beats/min for patients receiving V and +16.4 beats/min for those receiving V + P (P < .002 for change in HR), with two V + P patients developing tachycardia. It is concluded that the onset of neuromuscular blockade is more rapid in the distribution of the mandibular nerve than at the ulnar nerve; mandibular nerve stimulation is a better predictor of adequate intubating conditions; good intubating conditions can be attained with either V or V + P; and, rapid-sequence induction with V is safe from a cardiac standpoint as measured by changes in HR, but the addition of pancuronium is unnecessary.


Subject(s)
Anesthetics, Combined/administration & dosage , Coronary Artery Disease/surgery , Narcotics/administration & dosage , Neuromuscular Nondepolarizing Agents/administration & dosage , Pancuronium/administration & dosage , Vecuronium Bromide/administration & dosage , Anesthetics, Combined/adverse effects , Coronary Artery Bypass/methods , Dose-Response Relationship, Drug , Female , Fentanyl/administration & dosage , Heart Rate/drug effects , Humans , Intubation, Intratracheal/methods , Male , Mandibular Nerve/drug effects , Middle Aged , Muscle Relaxation/drug effects , Neuromuscular Nondepolarizing Agents/adverse effects , Pancuronium/adverse effects , Sufentanil/administration & dosage , Time Factors , Ulnar Nerve/drug effects , Vecuronium Bromide/adverse effects , Vocal Cords/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL